flecainide vs nirmatrelvir/ritonavir
Side-by-side comparison of flecainide and nirmatrelvir/ritonavir. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
major Known Drug Interaction
Antiarrhythmics amiodarone, dronedarone, flecainide, propafenone, quinidine ↑ antiarrhythmic Co-administration contraindicated due to potential for cardiac arrhythmias [see Contraindications (4) ] .
Recommendation: This combination must be avoided. Your doctor should prescribe a different medication that does not interact this way.
Tambocor
Paxlovid
Flecainide is a medicine used to prevent irregular heartbeats. It helps your heart beat normally.
Paxlovid is a medicine used to treat mild to moderate COVID-19 in adults. It helps prevent severe illness, hospitalization, or death in people at high risk.
This medicine can prevent fast heart rates in the upper chambers of the heart. This includes supraventricular tachycardia and atrial fibrillation/flutter. Flecainide can also prevent life-threatening fast heartbeats in the lower chambers (ventricles). It is usually started in the hospital for these serious ventricular problems.
Paxlovid treats mild to moderate COVID-19 in adults. You must be at high risk of your illness becoming severe. This includes needing to go to the hospital or possibly dying from COVID-19. Paxlovid is not for preventing COVID-19 before or after exposure.
Flecainide works by slowing down electrical signals in the heart. This helps to stabilize your heart rhythm. It belongs to a class of drugs called Class IC antiarrhythmics.
Paxlovid contains two medicines, nirmatrelvir and ritonavir. Nirmatrelvir stops the virus from multiplying in your body. Ritonavir helps nirmatrelvir stay in your body longer so it can work better.
- • Dizziness
- • Vision problems
- • Difficulty breathing
- • Headache
- • Nausea
- • Change in taste
- • Diarrhea
- Irregular heartbeat in the upper chambers 337
- Feeling tired 276
- Difficulty breathing 270
- Feeling lightheaded 255
- Feeling sick to your stomach 244
- COVID-19 22,774
- COVID-19 coming back 20,089
- Change in taste 7,316
- Diarrhea 4,003
- Feeling sick to your stomach 2,620
Flecainide can increase the risk of death or cardiac arrest in some patients who have had a heart attack. It is generally not recommended for people with less serious, but unpleasant, heart rhythm problems. Flecainide is also not recommended if you have chronic atrial fibrillation.
Paxlovid can interact with many other medicines, causing serious or life-threatening problems. Before taking Paxlovid, tell your doctor about all the medicines you take. Your doctor may need to adjust the dose of your other medicines or monitor you more closely.
Tell your doctor if you are pregnant or plan to become pregnant. It is not known if flecainide can harm an unborn baby. Talk to your doctor about the risks and benefits of taking flecainide while breastfeeding.
There is not enough information about nirmatrelvir's safety during pregnancy. Studies on ritonavir in pregnant women have not shown an increased risk of birth defects. Talk to your doctor about the risks and benefits of taking Paxlovid if you are pregnant or breastfeeding.
Also Compare, Nearby Drugs
Compare flecainide with
How to Read This flecainide vs nirmatrelvir/ritonavir Comparison
flecainide is classified in the Class IC Antiarrhythmic drug class, while nirmatrelvir/ritonavir sits within the Antiviral (Protease Inhibitor Combination) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, flecainide has 1,382 submissions while nirmatrelvir/ritonavir has 56,802. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known major interaction flagged in FDA labeling, attributed to ritonavir blocks the enzymes that process flecainide, leading to much higher levels of the heart drug in your system. this increase can cause the heart to beat in an unsafe or irregular way.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between flecainide and nirmatrelvir/ritonavir - always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.